世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ペット用糖尿病治療薬の世界市場シェアとランキング、全体売上高と需要予測 2025-2031

ペット用糖尿病治療薬の世界市場シェアとランキング、全体売上高と需要予測 2025-2031


Pet Diabetes Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

ペットの糖尿病治療の世界市場は、2024年に100万米ドルの価値があると推定され、2025年から2031年の予測期間中に%dのCAGRで2031年までに100万米ドルの再調整されたサイズになると予測されている。 当社のペット... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年3月28日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ペットの糖尿病治療の世界市場は、2024年に100万米ドルの価値があると推定され、2025年から2031年の予測期間中に%dのCAGRで2031年までに100万米ドルの再調整されたサイズになると予測されている。
当社のペット用品リサーチセンターによると、世界のペット産業は2022年に2610億ドルに達し、前年比11.3%増加した。米国はペット普及率が最も高く、最大のペット市場になる。アメリカペット用品協会(APPA)によると、アメリカの家庭の66%がペットを飼っており、業界全体の売上高は約1368億米ドルで、2021年より10.8%増加した。ドイツのペット用品業界団体IVHによると、2022年のドイツのペット飼育数は3,340万匹に達し、総売上高は65億ユーロ近くに達した。JDが発表した「2023年中国ペット産業動向洞察白書」によると、4大ペット現物商品の市場規模は年々増加しており、ペット用品が45%、ペット主食が35%近く、ペットスナックが12%、ペット薬と健康管理が40%を占めている。

本レポートは、ペット用糖尿病治療薬の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別のペット用糖尿病治療薬の分析とともに、総販売量、販売収益、価格、主要企業の市場シェアとランキングに焦点を当てています。
ペット用糖尿病治療薬の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データおよび予測データとともに、販売数量(Kユニット)および販売収益(百万ドル)で提供されます。量的および質的分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場での地位を分析し、ペットの糖尿病治療に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。

市場区分
企業別
カニンスリン
プロジンク
ベツリン
ハムリン
ヒューマログ
ランタス
レベミル
ノボリン
ノボログ
タイプ別セグメント
ベイト療法
インスリン製剤
経口血糖降下薬
用途別セグメント


地域別
北米
アメリカ
カナダ
アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア太平洋地域
ヨーロッパ
ドイツ
フランス
英国
イタリア
オランダ
北欧諸国
その他のヨーロッパ
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートの対象範囲、世界の総市場規模(金額、数量、価格)を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。
第2章:ペット糖尿病治療メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。
第3章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。
第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのに役立ちます。
第5章:地域レベルでのペット糖尿病治療薬の売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、市場規模を紹介しています。
第6章:国別ペット糖尿病治療薬の販売、収益。各国/地域のタイプ別、用途別のシグメイトデータを提供します。
第7章:主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:結論


ページTOPに戻る


目次

1 Market Overview
1.1 Pet Diabetes Treatment Product Introduction
1.2 Global Pet Diabetes Treatment Market Size Forecast
1.2.1 Global Pet Diabetes Treatment Sales Value (2020-2031)
1.2.2 Global Pet Diabetes Treatment Sales Volume (2020-2031)
1.2.3 Global Pet Diabetes Treatment Sales Price (2020-2031)
1.3 Pet Diabetes Treatment Market Trends & Drivers
1.3.1 Pet Diabetes Treatment Industry Trends
1.3.2 Pet Diabetes Treatment Market Drivers & Opportunity
1.3.3 Pet Diabetes Treatment Market Challenges
1.3.4 Pet Diabetes Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pet Diabetes Treatment Players Revenue Ranking (2024)
2.2 Global Pet Diabetes Treatment Revenue by Company (2020-2025)
2.3 Global Pet Diabetes Treatment Players Sales Volume Ranking (2024)
2.4 Global Pet Diabetes Treatment Sales Volume by Company Players (2020-2025)
2.5 Global Pet Diabetes Treatment Average Price by Company (2020-2025)
2.6 Key Manufacturers Pet Diabetes Treatment Manufacturing Base and Headquarters
2.7 Key Manufacturers Pet Diabetes Treatment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pet Diabetes Treatment
2.9 Pet Diabetes Treatment Market Competitive Analysis
2.9.1 Pet Diabetes Treatment Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Pet Diabetes Treatment Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Diabetes Treatment as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bait Therapy
3.1.2 Insulin Method
3.1.3 Oral Hypoglycemic Drugs
3.2 Global Pet Diabetes Treatment Sales Value by Type
3.2.1 Global Pet Diabetes Treatment Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pet Diabetes Treatment Sales Value, by Type (2020-2031)
3.2.3 Global Pet Diabetes Treatment Sales Value, by Type (%) (2020-2031)
3.3 Global Pet Diabetes Treatment Sales Volume by Type
3.3.1 Global Pet Diabetes Treatment Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Pet Diabetes Treatment Sales Volume, by Type (2020-2031)
3.3.3 Global Pet Diabetes Treatment Sales Volume, by Type (%) (2020-2031)
3.4 Global Pet Diabetes Treatment Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cat
4.1.2 Dog
4.2 Global Pet Diabetes Treatment Sales Value by Application
4.2.1 Global Pet Diabetes Treatment Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pet Diabetes Treatment Sales Value, by Application (2020-2031)
4.2.3 Global Pet Diabetes Treatment Sales Value, by Application (%) (2020-2031)
4.3 Global Pet Diabetes Treatment Sales Volume by Application
4.3.1 Global Pet Diabetes Treatment Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Pet Diabetes Treatment Sales Volume, by Application (2020-2031)
4.3.3 Global Pet Diabetes Treatment Sales Volume, by Application (%) (2020-2031)
4.4 Global Pet Diabetes Treatment Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Pet Diabetes Treatment Sales Value by Region
5.1.1 Global Pet Diabetes Treatment Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pet Diabetes Treatment Sales Value by Region (2020-2025)
5.1.3 Global Pet Diabetes Treatment Sales Value by Region (2026-2031)
5.1.4 Global Pet Diabetes Treatment Sales Value by Region (%), (2020-2031)
5.2 Global Pet Diabetes Treatment Sales Volume by Region
5.2.1 Global Pet Diabetes Treatment Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Pet Diabetes Treatment Sales Volume by Region (2020-2025)
5.2.3 Global Pet Diabetes Treatment Sales Volume by Region (2026-2031)
5.2.4 Global Pet Diabetes Treatment Sales Volume by Region (%), (2020-2031)
5.3 Global Pet Diabetes Treatment Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Pet Diabetes Treatment Sales Value, 2020-2031
5.4.2 North America Pet Diabetes Treatment Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Pet Diabetes Treatment Sales Value, 2020-2031
5.5.2 Europe Pet Diabetes Treatment Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Pet Diabetes Treatment Sales Value, 2020-2031
5.6.2 Asia Pacific Pet Diabetes Treatment Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Pet Diabetes Treatment Sales Value, 2020-2031
5.7.2 South America Pet Diabetes Treatment Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pet Diabetes Treatment Sales Value, 2020-2031
5.8.2 Middle East & Africa Pet Diabetes Treatment Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pet Diabetes Treatment Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pet Diabetes Treatment Sales Value
6.2.1 Key Countries/Regions Pet Diabetes Treatment Sales Value, 2020-2031
6.2.2 Key Countries/Regions Pet Diabetes Treatment Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Pet Diabetes Treatment Sales Value, 2020-2031
6.3.2 United States Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pet Diabetes Treatment Sales Value, 2020-2031
6.4.2 Europe Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pet Diabetes Treatment Sales Value, 2020-2031
6.5.2 China Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pet Diabetes Treatment Sales Value, 2020-2031
6.6.2 Japan Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pet Diabetes Treatment Sales Value, 2020-2031
6.7.2 South Korea Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pet Diabetes Treatment Sales Value, 2020-2031
6.8.2 Southeast Asia Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pet Diabetes Treatment Sales Value, 2020-2031
6.9.2 India Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Caninsulin
7.1.1 Caninsulin Company Information
7.1.2 Caninsulin Introduction and Business Overview
7.1.3 Caninsulin Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Caninsulin Pet Diabetes Treatment Product Offerings
7.1.5 Caninsulin Recent Development
7.2 Prozinc
7.2.1 Prozinc Company Information
7.2.2 Prozinc Introduction and Business Overview
7.2.3 Prozinc Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Prozinc Pet Diabetes Treatment Product Offerings
7.2.5 Prozinc Recent Development
7.3 Vetsulin
7.3.1 Vetsulin Company Information
7.3.2 Vetsulin Introduction and Business Overview
7.3.3 Vetsulin Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Vetsulin Pet Diabetes Treatment Product Offerings
7.3.5 Vetsulin Recent Development
7.4 Humulin
7.4.1 Humulin Company Information
7.4.2 Humulin Introduction and Business Overview
7.4.3 Humulin Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Humulin Pet Diabetes Treatment Product Offerings
7.4.5 Humulin Recent Development
7.5 Humalog
7.5.1 Humalog Company Information
7.5.2 Humalog Introduction and Business Overview
7.5.3 Humalog Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Humalog Pet Diabetes Treatment Product Offerings
7.5.5 Humalog Recent Development
7.6 Lantus
7.6.1 Lantus Company Information
7.6.2 Lantus Introduction and Business Overview
7.6.3 Lantus Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Lantus Pet Diabetes Treatment Product Offerings
7.6.5 Lantus Recent Development
7.7 Levemir
7.7.1 Levemir Company Information
7.7.2 Levemir Introduction and Business Overview
7.7.3 Levemir Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Levemir Pet Diabetes Treatment Product Offerings
7.7.5 Levemir Recent Development
7.8 Novolin
7.8.1 Novolin Company Information
7.8.2 Novolin Introduction and Business Overview
7.8.3 Novolin Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Novolin Pet Diabetes Treatment Product Offerings
7.8.5 Novolin Recent Development
7.9 NovoLog
7.9.1 NovoLog Company Information
7.9.2 NovoLog Introduction and Business Overview
7.9.3 NovoLog Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 NovoLog Pet Diabetes Treatment Product Offerings
7.9.5 NovoLog Recent Development
8 Industry Chain Analysis
8.1 Pet Diabetes Treatment Industrial Chain
8.2 Pet Diabetes Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pet Diabetes Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Pet Diabetes Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る


 

Summary

The global market for Pet Diabetes Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 40%.

This report aims to provide a comprehensive presentation of the global market for Pet Diabetes Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pet Diabetes Treatment by region & country, by Type, and by Application.
The Pet Diabetes Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Diabetes Treatment.

Market Segmentation
By Company
Caninsulin
Prozinc
Vetsulin
Humulin
Humalog
Lantus
Levemir
Novolin
NovoLog
Segment by Type
Bait Therapy
Insulin Method
Oral Hypoglycemic Drugs
Segment by Application
Cat
Dog
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pet Diabetes Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pet Diabetes Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pet Diabetes Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.



ページTOPに戻る


Table of Contents

1 Market Overview
1.1 Pet Diabetes Treatment Product Introduction
1.2 Global Pet Diabetes Treatment Market Size Forecast
1.2.1 Global Pet Diabetes Treatment Sales Value (2020-2031)
1.2.2 Global Pet Diabetes Treatment Sales Volume (2020-2031)
1.2.3 Global Pet Diabetes Treatment Sales Price (2020-2031)
1.3 Pet Diabetes Treatment Market Trends & Drivers
1.3.1 Pet Diabetes Treatment Industry Trends
1.3.2 Pet Diabetes Treatment Market Drivers & Opportunity
1.3.3 Pet Diabetes Treatment Market Challenges
1.3.4 Pet Diabetes Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pet Diabetes Treatment Players Revenue Ranking (2024)
2.2 Global Pet Diabetes Treatment Revenue by Company (2020-2025)
2.3 Global Pet Diabetes Treatment Players Sales Volume Ranking (2024)
2.4 Global Pet Diabetes Treatment Sales Volume by Company Players (2020-2025)
2.5 Global Pet Diabetes Treatment Average Price by Company (2020-2025)
2.6 Key Manufacturers Pet Diabetes Treatment Manufacturing Base and Headquarters
2.7 Key Manufacturers Pet Diabetes Treatment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pet Diabetes Treatment
2.9 Pet Diabetes Treatment Market Competitive Analysis
2.9.1 Pet Diabetes Treatment Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Pet Diabetes Treatment Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Diabetes Treatment as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bait Therapy
3.1.2 Insulin Method
3.1.3 Oral Hypoglycemic Drugs
3.2 Global Pet Diabetes Treatment Sales Value by Type
3.2.1 Global Pet Diabetes Treatment Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pet Diabetes Treatment Sales Value, by Type (2020-2031)
3.2.3 Global Pet Diabetes Treatment Sales Value, by Type (%) (2020-2031)
3.3 Global Pet Diabetes Treatment Sales Volume by Type
3.3.1 Global Pet Diabetes Treatment Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Pet Diabetes Treatment Sales Volume, by Type (2020-2031)
3.3.3 Global Pet Diabetes Treatment Sales Volume, by Type (%) (2020-2031)
3.4 Global Pet Diabetes Treatment Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cat
4.1.2 Dog
4.2 Global Pet Diabetes Treatment Sales Value by Application
4.2.1 Global Pet Diabetes Treatment Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pet Diabetes Treatment Sales Value, by Application (2020-2031)
4.2.3 Global Pet Diabetes Treatment Sales Value, by Application (%) (2020-2031)
4.3 Global Pet Diabetes Treatment Sales Volume by Application
4.3.1 Global Pet Diabetes Treatment Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Pet Diabetes Treatment Sales Volume, by Application (2020-2031)
4.3.3 Global Pet Diabetes Treatment Sales Volume, by Application (%) (2020-2031)
4.4 Global Pet Diabetes Treatment Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Pet Diabetes Treatment Sales Value by Region
5.1.1 Global Pet Diabetes Treatment Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pet Diabetes Treatment Sales Value by Region (2020-2025)
5.1.3 Global Pet Diabetes Treatment Sales Value by Region (2026-2031)
5.1.4 Global Pet Diabetes Treatment Sales Value by Region (%), (2020-2031)
5.2 Global Pet Diabetes Treatment Sales Volume by Region
5.2.1 Global Pet Diabetes Treatment Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Pet Diabetes Treatment Sales Volume by Region (2020-2025)
5.2.3 Global Pet Diabetes Treatment Sales Volume by Region (2026-2031)
5.2.4 Global Pet Diabetes Treatment Sales Volume by Region (%), (2020-2031)
5.3 Global Pet Diabetes Treatment Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Pet Diabetes Treatment Sales Value, 2020-2031
5.4.2 North America Pet Diabetes Treatment Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Pet Diabetes Treatment Sales Value, 2020-2031
5.5.2 Europe Pet Diabetes Treatment Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Pet Diabetes Treatment Sales Value, 2020-2031
5.6.2 Asia Pacific Pet Diabetes Treatment Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Pet Diabetes Treatment Sales Value, 2020-2031
5.7.2 South America Pet Diabetes Treatment Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pet Diabetes Treatment Sales Value, 2020-2031
5.8.2 Middle East & Africa Pet Diabetes Treatment Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pet Diabetes Treatment Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pet Diabetes Treatment Sales Value
6.2.1 Key Countries/Regions Pet Diabetes Treatment Sales Value, 2020-2031
6.2.2 Key Countries/Regions Pet Diabetes Treatment Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Pet Diabetes Treatment Sales Value, 2020-2031
6.3.2 United States Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pet Diabetes Treatment Sales Value, 2020-2031
6.4.2 Europe Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pet Diabetes Treatment Sales Value, 2020-2031
6.5.2 China Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pet Diabetes Treatment Sales Value, 2020-2031
6.6.2 Japan Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pet Diabetes Treatment Sales Value, 2020-2031
6.7.2 South Korea Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pet Diabetes Treatment Sales Value, 2020-2031
6.8.2 Southeast Asia Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pet Diabetes Treatment Sales Value, 2020-2031
6.9.2 India Pet Diabetes Treatment Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pet Diabetes Treatment Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Caninsulin
7.1.1 Caninsulin Company Information
7.1.2 Caninsulin Introduction and Business Overview
7.1.3 Caninsulin Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Caninsulin Pet Diabetes Treatment Product Offerings
7.1.5 Caninsulin Recent Development
7.2 Prozinc
7.2.1 Prozinc Company Information
7.2.2 Prozinc Introduction and Business Overview
7.2.3 Prozinc Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Prozinc Pet Diabetes Treatment Product Offerings
7.2.5 Prozinc Recent Development
7.3 Vetsulin
7.3.1 Vetsulin Company Information
7.3.2 Vetsulin Introduction and Business Overview
7.3.3 Vetsulin Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Vetsulin Pet Diabetes Treatment Product Offerings
7.3.5 Vetsulin Recent Development
7.4 Humulin
7.4.1 Humulin Company Information
7.4.2 Humulin Introduction and Business Overview
7.4.3 Humulin Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Humulin Pet Diabetes Treatment Product Offerings
7.4.5 Humulin Recent Development
7.5 Humalog
7.5.1 Humalog Company Information
7.5.2 Humalog Introduction and Business Overview
7.5.3 Humalog Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Humalog Pet Diabetes Treatment Product Offerings
7.5.5 Humalog Recent Development
7.6 Lantus
7.6.1 Lantus Company Information
7.6.2 Lantus Introduction and Business Overview
7.6.3 Lantus Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Lantus Pet Diabetes Treatment Product Offerings
7.6.5 Lantus Recent Development
7.7 Levemir
7.7.1 Levemir Company Information
7.7.2 Levemir Introduction and Business Overview
7.7.3 Levemir Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Levemir Pet Diabetes Treatment Product Offerings
7.7.5 Levemir Recent Development
7.8 Novolin
7.8.1 Novolin Company Information
7.8.2 Novolin Introduction and Business Overview
7.8.3 Novolin Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Novolin Pet Diabetes Treatment Product Offerings
7.8.5 Novolin Recent Development
7.9 NovoLog
7.9.1 NovoLog Company Information
7.9.2 NovoLog Introduction and Business Overview
7.9.3 NovoLog Pet Diabetes Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 NovoLog Pet Diabetes Treatment Product Offerings
7.9.5 NovoLog Recent Development
8 Industry Chain Analysis
8.1 Pet Diabetes Treatment Industrial Chain
8.2 Pet Diabetes Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pet Diabetes Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Pet Diabetes Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(pet)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/04 10:27

147.03 円

163.01 円

195.36 円

ページTOPに戻る